Recombinant CD40 (Sotigalimab Biosimilar) antibody

Catalog No. ABIN7598001

This Humanized Chimeric antibody specifically detects CD40 (Sotigalimab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant CD40 (Sotigalimab Biosimilar) antibody (ABIN7598001)

Target: CD40 (Sotigalimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD40 (Sotigalimab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-CD40 (Sotigalimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Sotigalimab Biosimilar Antibody

Specificity: Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, TNFRSF5, CDw40, CD40

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1.7 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD40 (Sotigalimab Biosimilar)

Target: CD40 (Sotigalimab Biosimilar)

Alternative Name: Sotigalimab Biosimilar

Target Type: Biosimilar

Background: Tumor necrosis factor receptor superfamily member 5, B-cell surface antigen CD40, Bp50, CD40L receptor, TNFRSF5, CDw40, CD40

UniProt: P25942

CAS-No: 2305607-45-6